Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study-Reference-Cited by-同舟云学术

Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study

Published:2021-05 Issue:5 Volume:53 Page:612-619
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Aghemo Alessio,Alberti Alfredo,Andreone Pietro,Angelico Mario,Brunetto Maurizia Rossana,Chessa Luchino,Ciancio Alessia,Craxì Antonio,Gaeta Giovanni Battista,Galli Massimo,Gasbarrini Antonio,Giorgini Alessia,Grilli Elisabetta,Lampertico Pietro,Lichtner Miriam,Milella Michele,Morisco Filomena,Persico Marcello,Pirisi Mario,Puoti Massimo,Raimondo Giovanni,Romano Antonietta,Russello Maurizio,Sangiovanni Vincenzo,Schiavini Monica,Serviddio Gaetano,Villa Erica,Vinci Maria,De Michina Antonella,Gallinaro Valentina,Gualberti Giuliana,Roscini Antonio Saverio,Zignego Anna Linda

Funder

Gilead Sciences

Angelini Pharma

Pfizer

AbbVie

Meso Scale Diagnostics

Bristol-Myers Squibb

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference41 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study;Lancet Gastroenterol Hepatol,2017

2. Effectiveness of current and future regimens for treating genotype 3 hepatitis C virus infection: a large-scale systematic review;Fathi;BMC Infectious Dis,2017

3. EASL recommendations on treatment of hepatitis C 2018;J Hepatol,2018

4. Treatment of chronic hepatitis C: efficacy, side effects and complications;Sandmann;Visc Med,2019

5. Treatment of hepatitis C virus infection with direct-acting antiviral agents: 100% cure?;Asselah;Liver Int.,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Effectiveness and Safety of Glecaprevir/Pibrentasvir for the Treatment of Chronic Hepatitis C: A Prospective Cohort Study in Portugal;Acta Médica Portuguesa;2024-02-07

2. Hepatitis C Virus Infection in the Elderly in the Era of Direct-Acting Antivirals: Evidence from Clinical Trials and Real Life;Tropical Medicine and Infectious Disease;2023-11-18

3. Kronik Hepatit C Hastalarında Uygulanan Direkt Etkili Antiviral Tedavinin Yaşam Kalitesi Üzerine Uzun Dönem Etkisinin Değerlendirilmesi;Medical Journal of Western Black Sea;2022-12-27

4. Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan;Scientific Reports;2021-12

5. Positive predictive value of sustained virologic response 4 weeks posttreatment for achieving sustained virologic response 12 weeks posttreatment in patients receiving glecaprevir/pibrentasvir in Phase 2 and 3 clinical trials;Journal of Viral Hepatitis;2021-09-08